Scientific work

Uzm. Dr. Umut Bakay

31 publications. The source of the information is stated next to each publication.

Back to profile

  1. Upadacitinib in Rheumatoid Arthritis After Prior TNF Inhibitor Failure: A 12-Month Multicenter Real-World Study

    Journal of Clinical Practice and Research, 2026

    DOI 10.14744/cpr.2026.21047 PMID 42676558 Open-access full textSource: OpenAlex

  2. Comment on: "Sirolimus versus mycophenolate mofetil for the treatment of lupus nephritis: Results from a real-world CSTAR cohort study"

    Rheumatology and immunology research, 2026

    DOI 10.1515/rir-2026-0009 PMID 41969818 Open-access full textSource: Europe PMC

  3. Preliminary Validation of the Early Sacroiliitis Screening Tool (ESHST) for Identifying Hidradenitis Suppurativa Patients at High Risk of Spondyloarthritis

    International journal of dermatology, 2026

    DOI 10.1111/ijd.70563 PMID 42381196 Open-access full textSource: Europe PMC

  4. Comment on: Impact of early immuno-suppressive therapy on pulmonary arterial hypertension in systemic sclerosis: a multicentre real-world study

    Clinical and Experimental Rheumatology, 2026

    DOI 10.55563/clinexprheumatol/tb4bnv PMID 41568444 Open-access full textSource: OpenAlex

  5. Right ventriculoarterial coupling as a marker of subclinical myocardial damage in rheumatoid arthritis: Comments on the study by Miranda-Aquino et al.

    Reumatología Clínica, 2026

    DOI 10.1016/j.reuma.2025.502044 Source: OpenAlex

  6. Letter to the Editor: IgG4-Related Orbital Disease from a Rheumatologist’s Perspective

    OSMANGAZİ JOURNAL OF MEDICINE, 2026

    DOI 10.20515/otd.1806503 Open-access full textSource: OpenAlex

  7. Right ventriculoarterial coupling as a marker of subclinical myocardial damage in rheumatoid arthritis: Comments on the study by Miranda-Aquino et al.

    Reumatología Clínica (English Edition), 2026

    DOI 10.1016/j.reumae.2026.502044 PMID 41786374 Source: OpenAlex

  8. Could microRNA-146a and microRNA-223 serve as biomarkers for predicting disease activity in rheumatoid arthritis patients?

    The Annals of Clinical and Analytical Medicine, 2026

    DOI 10.4328/acam.22719 Open-access full textSource: OpenAlex

  9. Sicca severity in primary Sjögren’s disease reflects symptom amplification rather than systemic inflammatory activity

    Turkish Journal of Clinics and Laboratory, 2026

    DOI 10.18663/tjcl.1846576 Open-access full textSource: OpenAlex

  10. Diagnostic accuracy and clinical utility of the EARP questionnaire for detecting early psoriatic arthritis: a Turkish multicenter validation study

    Reumatologia/Rheumatology, 2026

    DOI 10.5114/reum/217124 Open-access full textSource: OpenAlex

  11. Minor salivary gland biopsy in clinically suspected Sjögren's disease: still indispensable for seronegative cases?

    Zeitschrift fur Rheumatologie, 2025

    DOI 10.1007/s00393-025-01746-5 PMID 41168553 1 citation (Europe PMC) Source: Europe PMC

  12. Unveiling a spondyloarthritis-like phenotype in Sjögren's disease : clinical, serological, and radiological correlates of sacroiliitis in a real-world cohort

    Expert review of clinical immunology, 2025

    DOI 10.1080/1744666x.2025.2577669 PMID 41108553 Source: Europe PMC

  13. Comment on: "nociplastic pain in axial spondyloarthritis and psoriatic arthritis: role of JAK kinases in immunopathology and therapeutic impact of JAK inhibitors" by Horbal and Maksymowych

    Expert review of clinical immunology, 2025

    DOI 10.1080/1744666x.2025.2605306 PMID 41390945 Source: Europe PMC

  14. Comment on: "Association of MUC5B Promoter Variant With Interstitial Lung Disease in Systemic Sclerosis"

    International journal of rheumatic diseases, 2025

    DOI 10.1111/1756-185x.70474 PMID 41235719 Source: Europe PMC

  15. Hepatic Safety of IL-17 Inhibitors in Psoriasis and Psoriatic Arthritis: A 12-Month Retrospective Cohort Evaluation Using the FIB-4 Index

    Dermatology Practical & Conceptual, 2025

    DOI 10.5826/dpc.1601a6746 PMID 41912199 4 citations (OpenAlex) Open-access full textSource: OpenAlex

  16. A window into the vascular endothelium in COVID-19: Nails

    Dermatology Practical & Conceptual, 2025

    DOI 10.5826/dpc.1501a4927 PMID 39853249 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  17. Real-World Effectiveness and Safety of Upadacitinib in Tumor Necrosis FactorInhibitor Refractory Axial Spondyloarthritis: 52-Week Outcomes from a Single-Center Cohort

    Archives of Rheumatology, 2025

    DOI 10.5152/archrheumatol.2025.11098 PMID 41578768 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  18. Subclinical Spondyloarthritis Features in Patients with Hidradenitis Suppurativa: A Real-World Cross-Sectional Analysis

    Journal of Clinical Practice and Research, 2025

    DOI 10.14744/cpr.2025.87060 PMID 41347191 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  19. Upadacitinib in psoriatic arthritis with prior TNF-inhibitor failure: a 56-week real-world study

    Clinical and Experimental Rheumatology, 2025

    DOI 10.55563/clinexprheumatol/gniy9i PMID 41231514 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  20. ABS0948 COULD microRNA-146a AND microRNA-223 SERVE AS BIOMARKERS FOR PREDICTING DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS PATIENTS

    Annals of the Rheumatic Diseases, 2025

    DOI 10.1016/j.ard.2025.06.1627 Open-access full textSource: OpenAlex

  21. POS0488 AI-POWERED SCREENING FOR PSORIATIC ARTHRITIS: A COMPARATIVE STUDY WITH EXISTING TOOLS

    Annals of the Rheumatic Diseases, 2025

    DOI 10.1016/j.ard.2025.05.870 Open-access full textSource: OpenAlex

  22. Olgular Eşliğinde Genel Dahiliye II

    Akademisyen Kitabevi eBooks, 2025

    DOI 10.37609/akya.94 Open-access full textSource: OpenAlex

  23. Antı-Tnf Dirençli Aksiyel Spondiloartrit ve Vitiligo Birlikteliğinde Upadacitinib ile Tam Remisyon

    Akademisyen Kitabevi eBooks, 2025

    DOI 10.37609/akya.94.c1578 Open-access full textSource: OpenAlex

  24. Comment on: “Comprehensive analysis of patients with rheumatoid arthritis-associated interstitial lung disease” by Kim et al.

    The Korean Journal of Internal Medicine, 2025

    DOI 10.3904/kjim.2025.316 PMID 41430210 Open-access full textSource: OpenAlex

  25. Comment on “Real-world efficacy and retention of guselkumab in psoriatic arthritis: a 12-month multicenter study

    ARP Rheumatology, 2025

    DOI 10.63032/jkur6010 PMID 41480890 Open-access full textSource: OpenAlex

  26. IgG4 İlişkili Orbital Hastalık: Romatoloji Perspektifinden Editöre Mektup

    DergiPark (Istanbul University), 2025

    Source: OpenAlex

  27. Do Disease Parameters Related to Primary Sjögren's Syndrome have an Impact on the Severity of Co-Existing Fibromyalgia Syndrome or Vice Versa?

    Aktuelle Rheumatologie, 2024

    DOI 10.1055/a-2334-6194 Source: OpenAlex

  28. Could cognitive impairment manifest in Behçet's disease even in the absence of neurological symptoms?

    Pamukkale Medical Journal, 2024

    DOI 10.31362/patd.1584077 Open-access full textSource: ORCID

  29. A case of certolizumab-induced purpura annularis telangiectodes of Majocchi and literature review

    International journal of rheumatic diseases, 2024

    DOI 10.1111/1756-185x.14854 PMID 37522716 1 citation (Europe PMC) Source: Europe PMC

  30. Asemptomatik hiperüriseminin hidradenitis süppürativa hastalık seyrine etkileri

    Turkish Journal of Clinics and Laboratory, 2024

    DOI 10.18663/tjcl.1529053 Open-access full textSource: OpenAlex

  31. Romatoid artrit'te mikrorna-146A, mikrorna-223 düzeyleri, sensitive ve spesifiteleri, diğer hastalık parametreleri ve biyolojik ajan tedavisiyle ilişkisi / Serum microrna-146A and mi?crorna-223 levels, sensitivity and specificitys, relationship with disease parameters and treatment of biological agents in rheumatoid arthritis

    DSpace - FIRAT (Fırat University), 2016

    Open-access full textSource: OpenAlex